Illumina News and Activities

Presence

Illumina specializes in developing, manufacturing, and marketing integrated systems for the analysis of genetic variation and biological function. Their products primarily cater to genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.

Illumina products and services overview:

Sequencing instruments
Reagents
Chips and arrays
Bioinformatics software

2024 Revenue: Approximately $4.5 billion

Employees: 7,300

Illumina is one of the...

Illumina is a company listed under the stock ticker ILMN (US).

Illumina has 3 subsidiaries including Grail, Illumina Ventures and Pacific Biosciences.

They are in:

Acquisition, funding and merger involving Illumina.

Illumina has announced the acquisition of SomaLogic (posted on June 23 2025).

Executives

View the org chart displaying its 107 main executives

Most searched biographies at Illumina

Popular executive movements at Illumina

Salli Schwartz, Vice President of Investor Relations, has left the company (posted on April 22 2025).
Keith Meister will join the company as Director on Mar. 28, 2025 (posted on March 25 2025).

Create your alert
to follow the executive moves at Illumina.